Robert M. Califf

Professor of Medicine
Donald F. Fortin, M.D. Professor of Cardiology, in the School of Medicine
Member of the Duke Clinical Research Institute
Campus mail 100 Trent Drive, Suite401, Davison Building, Durham, NC 27710
Phone (919) 668-9222
Email address robert.califf@duke.edu

Robert Califf, MD MACC, is the Donald F. Fortin, MD, Professor of Cardiology. He is also Professor of Medicine in the Division of Cardiology and remains a practicing cardiologist. Dr. Califf was the Commissioner of Food and Drugs in 2016-2017 and  Deputy Commissioner for Medical Products and Tobacco from February 2015 until his appointment as Commissioner in February 2016. Prior to joining the FDA, Dr. Califf was a professor of medicine and vice chancellor for clinical and translational research at Duke University. He also served as director of the Duke Translational Medicine Institute and founding director of the Duke Clinical Research Institute. A nationally and internationally recognized expert in cardiovascular medicine, health outcomes research, healthcare quality, and clinical research, Dr. Califf has led many landmark clinical trials and is one of the most frequently cited authors in biomedical science, with more than 1,200 publications in the peer-reviewed literature.

Dr. Califf is a Member of the National Academy of Medicine (formerly known as the Institute of Medicine (IOM)) in 2016, one of the highest honors in the fields of health and medicine. Dr. Califf has served on numerous IOM committees, and he has served as a member of the FDA Cardiorenal Advisory Panel and FDA Science Board's Subcommittee on Science and Technology. Dr. Califf has also served on the Board of Scientific Counselors for the National Library of Medicine, as well as on advisory committees for the National Cancer Institute, the National Heart, Lung, and Blood Institute, the National Institute of Environmental Health Sciences and the Council of the National Institute on Aging.

He has led major initiatives aimed at improving methods and infrastructure for clinical research, including the Clinical Trials Transformation Initiative (CTTI), a public-private partnership co-founded by the FDA and Duke. He also served as the principal investigator for Duke's Clinical and Translational Science Award and the NIH Health Care Systems Research Collaboratory coordinating center and co-PI of the Patient Centered Outcomes Research Institute Network.

Associated Faculty Labs

Publications

Heinsimer, J. A., T. N. Skelton, and R. M. Califf. “Rate-related left bundle branch block with chest pain and normal coronary arteriograms treated by exercise training..” Am J Med Sci 292, no. 5 (November 1986): 317–19.

PMID
3777016
Scholars@Duke

Graham, M. L., R. Corey, R. Califf, and H. Phillips. “Isotretinoin and Staphylococcus aureus infection. A possible association..” Arch Dermatol 122, no. 7 (July 1986): 815–17.

PMID
3460532
Scholars@Duke

Lamas, G. A., J. E. Muller, Z. G. Turi, P. H. Stone, J. D. Rutherford, A. S. Jaffe, D. S. Raabe, R. E. Rude, D. B. Mark, and R. M. Califf. “A simplified method to predict occurrence of complete heart block during acute myocardial infarction..” Am J Cardiol 57, no. 15 (June 1, 1986): 1213–19.

PMID
3717016
Scholars@Duke

Lee, K. L., D. B. Pryor, F. E. Harrell, R. M. Califf, V. S. Behar, W. L. Floyd, J. J. Morris, R. A. Waugh, R. E. Whalen, and R. A. Rosati. “Predicting outcome in coronary disease. Statistical models versus expert clinicians..” Am J Med 80, no. 4 (April 1986): 553–60.

PMID
3963036
Scholars@Duke

Williams, R. B., T. L. Haney, R. A. McKinnis, F. E. Harrell, K. L. Lee, D. B. Pryor, R. Califf, Y. H. Kong, R. A. Rosati, and J. A. Blumenthal. “Psychosocial and physical predictors of anginal pain relief with medical management..” Psychosomatic Medicine 48, no. 3–4 (March 1986): 200–210. https://doi.org/10.1097/00006842-198603000-00005.

PMID
2871582
Full Text

Heinsimer, J. A., T. N. Skelton, and R. M. Califf. “Case report: Rate-related left bundle branch block with chest pain and normal coronary arteriograms treated by exercise training.” American Journal of the Medical Sciences 292, no. 5 (January 1, 1986): 317–19. https://doi.org/10.1097/00000441-198611000-00013.

Full Text

Califf, R. M., M. A. Hlatky, D. B. Mark, K. L. Lee, F. E. Harrell, R. A. Rosati, and D. B. Pryor. “Randomized trials of coronary artery bypass surgery: Impact on clinical practice at Duke University Medical Center.” Circulation 72, no. 6 II MONGR. (December 1, 1985).

Scholars@Duke

Califf, R. M., M. A. Hlatky, D. B. Mark, K. L. Lee, F. E. Harrell, R. A. Rosati, and D. B. Pryor. “Randomized trials of coronary artery bypass surgery: impact on clinical practice at Duke University Medical Center..” Circulation 72, no. 6 Pt 2 (December 1985): V136–44.

PMID
2933183
Scholars@Duke

White, R. D., P. Grande, L. Califf, S. T. Palmeri, R. M. Califf, and G. S. Wagner. “Diagnostic and prognostic significance of minimally elevated creatine kinase-MB in suspected acute myocardial infarction..” Am J Cardiol 55, no. 13 Pt 1 (June 1, 1985): 1478–84.

PMID
4003289
Scholars@Duke

White, R. D., P. Grande, L. Califf, S. T. Palmeri, R. M. Califf, and G. S. Wagner. “Diagnostic and prognostic significance of minimally elevated creatine kinase-mb in suspected acute myocardial infarction.” The American Journal of Cardiology 55, no. 13 (June 1, 1985): 1478–84. https://doi.org/10.1016/0002-9149(85)90957-9.

Full Text

Pages